These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12463275)

  • 1. Ergotamine, dihydroergotamine: current uses and problems.
    Tfelt-Hansen P
    Curr Med Res Opin; 2001; 17 Suppl 1():s30-4. PubMed ID: 12463275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergotamine and dihydroergotamine: a review.
    Bigal ME; Tepper SJ
    Curr Pain Headache Rep; 2003 Feb; 7(1):55-62. PubMed ID: 12525272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P; Ricalde O; Le Force B; Saper J; Margul B
    Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Lipton RB
    Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
    Dahlöf C; Maassen Van Den Brink A
    Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.
    Saper JR; Silberstein S
    Headache; 2006 Nov; 46 Suppl 4():S171-81. PubMed ID: 17078849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
    Touchon J; Bertin L; Pilgrim AJ; Ashford E; Bès A
    Neurology; 1996 Aug; 47(2):361-5. PubMed ID: 8757005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT
    Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer intranasal migraine medications.
    Logemann CD; Rankin LM
    Am Fam Physician; 2000 Jan; 61(1):180-6. PubMed ID: 10643958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan (rectal route of administration) for acute migraine attacks in adults.
    Derry CJ; Derry S; Moore RA
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD009664. PubMed ID: 22336868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medication-overuse headache].
    Rabe K; Katsarava Z
    MMW Fortschr Med; 2006 Aug; 148(35-36):37-8. PubMed ID: 16995362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute treatment of migraine attacks.
    Ferrari MD; Haan J
    Curr Opin Neurol; 1995 Jun; 8(3):237-42. PubMed ID: 7551126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD
    Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
    Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW
    Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble.
    Henry P; d'Allens H
    Headache; 1993 Sep; 33(8):432-5. PubMed ID: 8262783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral sumatriptan for acute migraine.
    McCrory DC; Gray RN
    Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Headache currents commentary.
    Peatfield R
    Headache; 2012 Apr; 52(4):715. PubMed ID: 22414189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology.
    Silberstein SD; Young WB
    Neurology; 1995 Mar; 45(3 Pt 1):577-84. PubMed ID: 7898722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.